Loading…

Browse All Grants

20,252 grants found

Filters
Reset

Showing 19,68119,700 of 20,252 grants

Completed NON-SBIR/STTR RPGS
Delineating developmental programs driving tumorigenesis in triple-negative breast cancer
NATIONAL CANCER INSTITUTE Stanford University United States 2021 – 2026

PROJECT SUMMARY Triple-negative breast cancer (TNBC) is the deadliest and 2nd most common subtype of breast cancer in the United States. Although promising new drugs based on PARP...

$5.16M
USD
Completed NON-SBIR/STTR RPGS
Investigating Macrophage Molecular and Functional Diversity in Tumor Immunity
NATIONAL CANCER INSTITUTE Icahn School of Medicine At Mount Sinai United States 2021 – 2026

PROJECT SUMMARY Macrophages (MF) are one of the largest immune cell components of tumor lesions, where their numbers can even exceed cancer cells. MF play a key role in shaping the...

$6.85M
USD
Completed NON-SBIR/STTR RPGS
RESISTANCE AND RESPONSE SIGNALING TO PARP1 INHIBITORS IN OVARIAN CANCER
NATIONAL CANCER INSTITUTE H. Lee Moffitt Cancer Ctr & Res Inst United States 2021 – 2024

The last twenty years have seen significant progress in ovarian cancer treatment, in particular for the women carrying pathogenic variants in BRCA1 or BRCA2. The foundation for thi...

$1.89M
USD
Completed NON-SBIR/STTR RPGS
Neoadjuvant PD-1 blockade in mismatch repair deficient rectal cancer
NATIONAL CANCER INSTITUTE Sloan-Kettering Inst Can Research United States 2021 – 2024

ABSTRACT Rectal cancer is treated with induction chemotherapy followed by chemoradiationand subsequentsurgery. Most patients who have undergone this sequential treatment approach h...

$2.03M
USD
Completed NON-SBIR/STTR RPGS
Bayesian Network-Based Integrative Genomics Methods for Precision Medicine
NATIONAL CANCER INSTITUTE University of Pennsylvania United States 2021 – 2025

Project Summary/Abstract Modern multi-platform genomic data sets contain substantial molecular information potentially useful for discovering new precision therapeutic strategies....

$4.34M
USD
Completed OTHER RESEARCH-RELATED
Investigation of the Carcinogenic Effects of Bactericidal Antibiotics in the Gut
NATIONAL CANCER INSTITUTE Harvard University United States 2021 – 2025

Project Summary/Abstract Colitis-associated cancer (CAC) refers to the pathological transition from inflammatory bowel disease (IBD) to colorectal cancer (CRC). Burgeoning evidence...

$921.9K
USD
Completed NON-SBIR/STTR RPGS
Peer Coaching for Physical Activity Promotion among Breast Cancer Survivors: Adapting an Efficacious Intervention to Prepare for Implementation
NATIONAL CANCER INSTITUTE University of South Carolina At Columbia United States 2021 – 2025

Interventions promoting physical activity among cancer survivors improve their functioning, reduce fatigue and offer other benefits in cancer recovery and risk reduction for future...

$3.32M
USD
Completed NON-SBIR/STTR RPGS
Discovering the role of YES1 in triple negative breast cancer
NATIONAL CANCER INSTITUTE Cleveland Clinic Lerner Com-Cwru United States 2021 – 2026

PROJECT SUMMARY/ABSTRACT SRC Family Kinases (SFKs) are a group of 9 non-receptor tyrosine kinases that mediate the effects of many extracellular and intracellular signaling pathway...

$4.52M
USD
Completed NON-SBIR/STTR RPGS
Peer Coaching for Physical Activity Promotion among Breast Cancer Survivors: Adapting an Efficacious Intervention to Prepare for Implementation
NATIONAL CANCER INSTITUTE University of South Carolina At Columbia United States 2021 – 2025

Interventions promoting physical activity among cancer survivors improve their functioning, reduce fatigue and offer other benefits for cancer recovery and risk reduction for futur...

$1.42M
USD
Completed NON-SBIR/STTR RPGS
Development of selective HDAC6 inhibitors to improve cancer immunotherapy
NATIONAL CANCER INSTITUTE Georgetown University United States 2021 – 2026

Project Summary The median survival for metastatic melanoma is approximately 8–16 months, and few therapies offer a significant improvement in overall survival. However, immunother...

$5.14M
USD
Completed OTHER RESEARCH-RELATED
Improving sleep in gynecologic cancer survivors
NATIONAL CANCER INSTITUTE University of Arizona United States 2021 – 2026

PROJECT SUMMARY Sleep disturbance is one of the primary complaints of gynecologic cancer survivors, with more than 80% of survivors reporting sleep difficulties. Sleep disturbance...

$1.75M
USD
Completed OTHER RESEARCH-RELATED
Gasdermin E-mediated pyroptosis in promoting antitumor immunity and cancer treatment
NATIONAL CANCER INSTITUTE Boston Children'S Hospital United States 2021 – 2022

Project Summary/Abstract The majority of cancers, which are immunologically “cold” with limited T cell infiltration, show abysmal response rates to immunotherapy. Novel strategies...

$1.12M
USD
Completed TRAINING, INDIVIDUAL
Identifying targets for combination therapy with FOLFIRINOX and investigating cell polarity loss as a potential driver of invasion in basal-like PDAC
NATIONAL CANCER INSTITUTE University of North Carolina Chapel Hill United States 2021 – 2024

Abstract Pancreatic ductal adenocarcinoma (PDAC) is a lethal disease with a dismal five-year survival rate of 9% even with current treatments. There are two molecular tumor subtype...

$351.7K
USD
Completed TRAINING, INDIVIDUAL
Multimodal computational models to stratify ovarian cancer patients
NATIONAL CANCER INSTITUTE Weill Medical Coll of Cornell Univ United States 2021 – 2022

Project Summary/Abstract High-grade serous ovarian cancer (HGSC) is the most lethal gynecologic malignancy, with a five-year survival rate of less than 30% for metastatic disease....

$318.1K
USD
Completed TRAINING, INDIVIDUAL
Metabolically improving the generation, function, and persistence of therapeutic T cells for the treatment of cancer
NATIONAL CANCER INSTITUTE University of Pittsburgh At Pittsburgh United States 2021 – 2023

Project Summary Immunotherapy has shifted the paradigm in the understanding and treatment of cancer. Within this arsenal of new treatment strategies, adoptive cell therapy (ACT) ha...

$467.5K
USD
Completed NON-SBIR/STTR RPGS
Targeting immunosuppressive adenosine in patients with metastatic non-small cell lung cancer
NATIONAL CANCER INSTITUTE Ohio State University United States 2021 – 2026

SUMMARY/ABSTRACT Immune checkpoint inhibitors (ICIs) have transformed the management of patients with metastatic non-small cell lung cancer (NSCLC). Unfortunately, over 50% of pati...

$5.6M
USD
Active NON-SBIR/STTR RPGS
Targeting B7-H3 in ovarian cancer
NATIONAL CANCER INSTITUTE University of North Carolina Chapel Hill United States 2021 – 2027

ABSTRACT Remarkable clinical responses have been reported in B-cell malignancies by adoptive transfer of T cells redirected with a chimeric antigen receptor (CAR) specific for the...

$1.09M
USD
Completed NON-SBIR/STTR RPGS
Regulation of Ku70 methylation and functions by SETD4
NATIONAL CANCER INSTITUTE Rutgers Biomedical and Health Sciences United States 2021 – 2026

Regulation of Ku70 Methylation and Functions by SETD4 (Abstract) The objective of this study is to elucidate a novel regulatory mechanism of Ku70 functions that are controlled by l...

$3.52M
USD
Completed TRAINING, INDIVIDUAL
Investigating macrophage-to-tumor mitochondrial transfer
NATIONAL CANCER INSTITUTE University of Utah United States 2021 – 2023

Project Summary Tumor metastasis is the leading cause of cancer related mortalities, yet preventing this malignant phenotype continues to elude scientific investigators. In efforts...

$251.2K
USD
Completed TRAINING, INDIVIDUAL
Characterization of ILEI/LIFR Axis-induced Intracellular Signaling
NATIONAL CANCER INSTITUTE Medical University of South Carolina United States 2021 – 2023

Project Summary Our lab has previously identified a mechanism of transforming growth factor beta (TGFβ)-mediated epithelial-to-mesenchymal transition (EMT) in murine mammary epithe...

$425.7K
USD